Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value—A Multicenter Study From South India

Shashidhar V. Karpurmath, Arun Seshachalam, Kalaiselvi Selvaraj, Priyadarshini Rajamani, Satish kumar, Neelesh Reddy, Baswant Malipatil, Roopa Sirigeri, Krishna Prasad, Krishna Reddy, Madhav Danthala, Karthik S. Udupa, Manjunath Nandennavar, Janarthinakani Murugesan, C. N. Patil, Parameswaran Anoop, Roshan Koshy Jacob, Mallikarjun Kalashetty, Krishnakumar Rathnam, Ramanan Ganapathy

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint Dive into the research topics of 'Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value—A Multicenter Study From South India'. Together they form a unique fingerprint.

Medicine & Life Sciences